期刊
PROTEOMICS CLINICAL APPLICATIONS
卷 3, 期 10, 页码 1140-1150出版社
WILEY-V C H VERLAG GMBH
DOI: 10.1002/prca.200780035
关键词
Cancer; Drug discovery; Quantitative biology; Reverse-phase protein array; Systems biology
资金
- National Genome Research Net (NGFN)
- German Federal Ministry for Education and Research (BMBF) [PTJ-Bio/0313336]
- [01GR0418]
A detailed and quantitative analysis of disease-relevant signaling will greatly contribute to our understanding of tumorigenesis and cancer progression, and thus open new strategies for drug discovery. However, throughput and sensitivity of currently established methods available for proteome profiling do not comply with the needs of clinical research such as high sample capacity and low sample consumption. Protein microarrays emerged as a promising alternative to analyze the abundance of proteins and their phosphorylation status on a high-throughput level. Here we summarize recent methodological advancements in the field of reverse-phase protein arrays and demonstrate their potential for clinical research as well as for in vitro applications.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据